Verition Fund Management LLC Catalyst Biosciences, Inc. Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$3.78 - $5.18 $1.46 Million - $2.01 Million
-387,101 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$4.1 - $5.33 $431,705 - $561,217
105,294 Added 37.36%
387,101 $1.68 Million
Q1 2021

May 18, 2021
SELL
$4.93 - $7.15 $98,959 - $143,521
-20,073 Reduced 6.65%
281,807 $1.42 Million
Q4 2020

Feb 16, 2021
BUY
$4.55 - $7.29 $1.37 Million - $2.2 Million
301,880 New
301,880 $1.91 Million

Others Institutions Holding CBIO

# of Institutions
1
Shares Held
215
Call Options Held
0
Put Options Held
0
View Full List

About CATALYST BIOSCIENCES, INC.

CBIO Quotes by TradingView
  • Ticker CBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,477,100
  • Description
  • Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...
More about CBIO
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email